Keyphrases
6-cycles
15%
Adenocarcinoma
20%
Advanced Stage
20%
Autophagy
61%
Cancer Patients
22%
CD56
15%
CD99
15%
CDDP
20%
Chemotherapy
61%
Clinical Examination
15%
Cytokeratin
30%
Day Hospital
61%
Deep Vein Thrombosis
20%
Diacylglycerol Kinase
61%
Disease Progression
15%
Disease Stage
20%
Eastern Cooperative Oncology Group Performance Status (ECOG PS)
20%
Epigenetic Control
61%
Epistaxis
15%
Ethmoid Sinus
61%
Ewing Sarcoma
46%
Extraskeletal
30%
First-line Chemotherapy
15%
Fluorescence in Situ Hybridization
15%
Intracranial Extension
61%
Italy
61%
Kinase Inhibitor
61%
Localized Disease
15%
Magnetic Resonance Imaging
15%
Male Patients
15%
Microscopic Examination
15%
Neuron-specific Enolase
15%
Non-coding RNA (ncRNA)
61%
Non-small Cell Lung Cancer (NSCLC)
51%
Non-small Cell Lung Cancer Patients
61%
Oncology
61%
Pharmacophoric
61%
Primary Ewing Sarcoma
61%
Quality of Life
15%
Rare Case Report
61%
Research Biopsy
15%
Restaging
15%
Retrospective Analysis
61%
Sinonasal Tract
61%
Sphenoid Sinus
61%
Structure-activity Relationship Studies
61%
Thromboprophylaxis
20%
Tumor
61%
Venous Thromboembolism
61%
Visual Acuity
15%
Medicine and Dentistry
Acetylsalicylic Acid
8%
Adenocarcinoma
17%
Anosmia
15%
Anterior Cranial Fossa
15%
Biopsy Technique
15%
Body Mass Index
8%
Cancer Therapy
8%
Carcinoma
15%
Central Venous Catheter
8%
Chemotherapy
8%
Cisplatin
8%
Clinical Examination
15%
Clinical Trial
8%
Combination Therapy
8%
Cumulative Incidence
8%
Cytokeratin
15%
Deep Vein Thrombosis
17%
Disease Exacerbation
15%
Endoscope
15%
Epistaxis
15%
Ethmoid Sinus
61%
Ewing Sarcoma
61%
First-Line Chemotherapy
15%
Fluorescence in Situ Hybridization
15%
Functional Status
15%
Headache
15%
Large Cell Carcinoma
8%
Lung Cancer
17%
Magnetic Resonance Imaging
15%
Magnetic Resonance Imaging of the Brain
15%
Malignant Neoplasm
8%
Neck
15%
Neoplasm
15%
Neuron Specific Enolase
15%
Non Small Cell Lung Cancer
61%
Oncology
61%
Outpatient
8%
Periodic Acid-Schiff Stain
15%
Quality of Life
15%
Radiation Therapy
15%
Recurrent Disease
15%
Second-Line Chemotherapy
15%
Small Cell Lung Cancer
8%
Sphenoidal Sinus
61%
Synaptophysin
15%
Thromboembolism
17%
Thromboprophylaxis
8%
Venous Thromboembolism
61%
Vimentin
15%
Visual Acuity
15%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
7%
Adenocarcinoma
15%
Anticoagulant Agent
7%
Cancer Growth
20%
Cancer Recurrence
20%
Carcinogenesis
20%
Chemotherapy
61%
Cisplatin
7%
Clinical Trial
7%
Combination Therapy
7%
Deep Vein Thrombosis
15%
Diacylglycerol Kinase
15%
Diacylglycerol Kinase Inhibitor
61%
Diseases
28%
Drug Resistance
20%
Erythropoietin
7%
Gene Targeting
20%
IC50
15%
Large Cell Carcinoma
7%
Long Untranslated RNA
20%
Low Molecular Weight Heparin
7%
Lung Cancer
15%
Lymphoproliferative Disease
15%
Malignant Neoplasm
100%
microRNA
20%
Neoplasm
61%
Non Small Cell Lung Cancer
61%
Serotonin Receptor
15%
Small Cell Lung Cancer
7%
Squamous Cell Carcinoma
7%
Structure Activity Relationship
61%
Thromboembolism
15%
Tumor Promoter
20%
Tumor Suppressor Protein
20%
Untranslated RNA
61%
Venous Thromboembolism
61%
Virtual Screening
15%
